These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The nonprophylactic role of cephalosporins in obstetrics and gynecology. LeFrock JL; Smith BR; Molavi A Bull N Y Acad Med; 1984 May; 60(4):416-25. PubMed ID: 6372917 [No Abstract] [Full Text] [Related]
13. Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections. Sweet RL; Gall SA; Gibbs RS; Hemsell DL; Knuppel RA; Lane TW; Miller RD; Newton ER; Poindexter AN; Reguero W Am J Surg; 1988 May; 155(5A):56-60. PubMed ID: 3287970 [TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on cefoxitin in the field of obstetrics and gynecology]. Cho N; Suzuki H; Itagaki T; Hirai N; Seki M; Kondo H; Nishimoto S; Togo M; Simizu S; Ozaki T Jpn J Antibiot; 1985 Feb; 38(2):212-22. PubMed ID: 4009945 [TBL] [Abstract][Full Text] [Related]
15. Study of cefotaxime in the treatment of obstetric and gynaecological infections. Soutoul JH; Quentin R; Boscq G; Chazara C; Prieur D J Antimicrob Chemother; 1980 Sep; 6 Suppl A():283-5. PubMed ID: 6252172 [No Abstract] [Full Text] [Related]
16. Evaluation of cefoxitin sodium therapy in anaerobic infections. Thadepalli H; Webb D; Roy I; Bach V J Antimicrob Chemother; 1978 Jul; 4(B):203-8. PubMed ID: 357387 [No Abstract] [Full Text] [Related]
17. Use of expanded spectrum cephalosporins for the treatment of obstetrical and gynecological infections. Mercer LJ Obstet Gynecol Surv; 1988 Sep; 43(9):569-75. PubMed ID: 3145476 [TBL] [Abstract][Full Text] [Related]